Skip to content

Effects of abdominal moxibustion on postoperative gastrointestinal function recovery and intestinal microflora of patients undergoing spinal surgery

Effects of abdominal moxibustion on postoperative gastrointestinal function recovery and intestinal microflora of patients undergoing spinal surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054938
Enrollment
Unknown
Registered
2021-12-29
Start date
2022-01-03
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative period

Interventions

Experimental group:Basic treatment + abdominal moxibustion

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective spinal surgery under endotracheal general anesthesia; 2. Age 18-65 years; 3. American Society of Anesthesiologists (ASA) grade I-III; 4. The patient had fully understood the study and voluntarily signed a written informed consent before the study began.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to moxibustion and resistant to moxibustion cannot be treated or those who are unable to perform moxibustion due to diseases existing in the surface area of acupoints involved in this study; 2. Preoperative conscious cognitive, visual and auditory impairment or doctor-patient communication difficulties, unable to complete gastrointestinal function measurement; 3. Patients with intestinal functional organic lesions; 4. Diabetes, hyperthyroidism and hypoimmune deficiency intestinal parasitic diseases with severe hypoproteinemia (albumin < 30 g/L) severe electrolyte disturbances such as hypokalemia (blood K+ < 2.5 mmol/L) traumatic T6 and below fracture may cause visceral motor nerve injury; 5. A large number of hormones or non-steroidal anti-inflammatory agents were used in the last 2 weeks to affect electrolyte metabolism; 6. Patients who were simultaneously treated preoperatively with drugs that affected the efficacy evaluation of this study (such as Smecta, dexide, cisapride, etc.); 7. Previous history of schizophrenia, Parkinson's disease or epilepsy.

Design outcomes

Primary

MeasureTime frame
The time to the first passage of flatus after surgery;The time to the first defecation after surgery;The time to first Bowel sound recovery;

Secondary

MeasureTime frame
GSRS (Gastrointestinal Symptom Rating Scale);Inflammatory markers and nutritional status assessment;Identification of intestinal flora;

Countries

China

Contacts

Public ContactYe Fei

Guangdong Provincial Hospital of Chinese Medicine

yepainclinic@163.com+86 18903055084

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026